January 25, 2024 C-Path Promotes Cécile Ollivier to Vice President of Global Affairs, Expanding Leadership in Drug Development Critical Path Institute (C-Path) today announced the promotion of Cécile Ollivier, M.S., from Managing Director, Europe to...
December 21, 2023 Flexible approaches to eCOA administration in clinical trials: The site perspective The Critical Path Institute convened the Support Flexible Approaches to PRO Data Collection project as part of the eCOA: Gettin
October 3, 2023 C-Path Rare and Orphan Disease Conference Highlights Unprecedented Collaborations and Breakthroughs in Rare Disease Research TUCSON, Ariz., October 3, 2023 — The Critical Path Institute (C-Path) held its highly anticipated Rare and Orphan Disease Confer
July 20, 2023 TTC Announces Publication in Transplantation C-Path’s Transplant Therapeutics Consortium is pleased to announce the recent publication in Transplantation by William Fit
May 31, 2023 C-Path’s Transplant Therapeutics Consortium’s Work Highlighted in Recent Publication in the American Journal of Transplantation C-Path’s Transplant Therapeutics Consortium is pleased to announce the recent publication in the American Journal of Transplan
March 29, 2023 C-Path Appoints Key Scientific Leaders to Executive Roles Critical Path Institute (C-Path) announced today the appointment of three accomplished leaders to key executive roles within the..
March 15, 2023 Evaluation of Novel Urinary Biomarkers in Beagle Dogs With Amphotericin B-Induced Kidney Injury
December 16, 2022 eCOA Consortium and PRO Consortium Announce Publication of Two Open Access Articles C-Path’s eCOA Consortium and PRO Consortium are pleased to announce the publication of two open access articles in the Jour
June 8, 2022 PRO Consortium Announces Publication of Open Access Article C-Path’s PRO Consortium is pleased to announce that “Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ)
